In a Nutshell
As a neuroscientist studying the opioid epidemic, Yasmin Hurd focuses on non-addictive, efficacious treatments in overcoming addiction with Cannabidiol (CDB).
More about Yasmin
Internationally renowned neuroscientist Yasmin Hurd’s ground-breaking cannabidiol studies are leading the development of potential treatment for opioid addiction and other disorders. She uses multidisciplinary research approaches to highlight the complex neurobiological mechanisms underlying addiction vulnerability. Her work includes the study of epigenetic disturbances as key contributions to the long-term impact of drugs on both the brain and behavior enhancing psychiatric vulnerability. Her work studying the human brain and complementary translational animal models flourishes at the intersection of molecular biology, behavioral neuropharmacology, neuroimaging, and genetics. At the Icahn School of Medicine in New York, Yasmin is a Professor of Psychiatry, Neuroscience and Pharmacological Sciences and the Ward-Coleman Chair in Translational Neuroscience. Yasmin directs the Addiction Institute in the Mount Sinai Behavioral Health System, covering one of the largest addiction populations in the US. Yasmin is a National Academy of Medicine inductee.